Biogen to cease production of controversial Alzheimer's drug
## Biogen to stop manufacturing controversial Alzheimer’s medication Biogen’s chief executive, Christopher A. Viehbacher, expressed the significance of breakthroughs in creating new drugs and the impacts they have on future developments. The